MAIN


©1996-2009 All Rights Reserved. Online Journal of Bioinformatics. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be reproduced or re-transmitted without the express permission of the editors.


OJB©

Online Journal of Bioinformatics©
 

Volume 5 : 129-131, 2004


In silico gene identification and homology modeling of Chorismate synthase in Clostridium difficile

 

Sunita T, Ramadevi S

 

Informatics Division, GVK BIOSCIENCES Pvt Ltd, Hyderabad, India


ABSTRACT

 

Sunita T, Ramadevi S In silico gene identification and homology modeling of Chorismate synthase in Clostridium difficile Online J Bioinformatics 5 :129-131, 2004. Chorismate synthase (EC 4.2.3.5), catalyzes the last step in the common shikimate pathway leading to aromatic compounds. The shikimate pathway is absent in animals but present in bacteria, fungi, algae and parasites.  Chorismate synthase  is a potential therapeutic target for the rational design of novel antibacterials, antifungals, antiprotozoals, and herbicides. Herein is described the identification of gene for chorismate synthase in unfinished genome of Clostridium difficile, a gram positive bacteria involved in colitis and diarrhea. The predicted protein sequence has three conserved signature  patterns from regions rich in basic residues (mostly arginines) present in chorismate synthase of various species.  Homology modeling studies based on the crystal structure of chorismate synthase from Helicobacter pylori showed the conserved FMN binding site with two invariant histidine residues conserved in the active site : His(17) and His(106). The homology model described herein  should provide a structural framework on which the design of specific inhibitors may be based.

 

Keywords: aroC; chorismate synthase; FMN-binding protein; Clostridium difficile; shikimate pathway


MAIN

 

FULL-TEXT (SUBSCRIBERS)